Home > Products

Products

Bone and Joint Diseases

Actemra Solution for Infusion

Indications:

  1. Rheumatoid Arthritis (RA):
    ACTEMRA in combination with methotrexate (MTX) is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (DMARDs) or tumor necrosis factor (TNF) antagonists. In these patients, ACTEMRA can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate.
  2. Rheumatoid Arthritis (RA) - MTX naïve RA:
    ACTEMRA in combination with methotrexate (MTX) is indicated for the treatment of severe, active and progressive rheumatoid arthritis in adult patients not previously treated with MTX. In these patients, ACTEMRA can be given as monotherapy in case of intolerant to MTX or where continued treatment with MTX is inappropriate. ACTEMRA has been shown to reduce the rate of progression of joint damage as measured by X-ray when given in combination with methotrexate.
  3. Polyarticular Juvenile Idiopathic Arthritis (PJIA):
    ACTEMRA in combination with methotrexate (MTX) is indicated for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) in patients 2 years of age and older, who have responded inadequately to previous therapy with MTX. Actemra can be given as monotherapy in case of intolerance to MTX or where continued treatment with MTX is inappropriate.
  4. Systemic Juvenile Idiopathic Arthritis (SJIA):
    ACTEMRA is indicated for the treatment of active systemic juvenile idiopathic arthritis (sJIA) in patients 2 years of age and older, who have responded inadequately to previous therapy with NSAIDs and systemic corticosteroids.

Actemra 200mg Solution for Infusion Actemra 200mg Solution for Infusion

Actemra 80mg Solution for Infusion Actemra 80mg Solution for Infusion

Actemra Solution for SC Injection

Indications:

  1. Rheumatoid Arthritis(RA):
    Actemra may be used as concomitantly with methotrexate (MTX) in adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response to one or more Disease-Modifying Anit-Rheumatic Drugs (DMARD) or TNF Antagonist. ACTEMRA may be used as monotherapy, if the patients who have had an inadequate response to MTX.
  2. Giant Cell Arteritis(GCA):
    Actemra is indicated for the treatment of giant cell arteritis (GCA) in adult patients.

Actemra 162mg for SC Injection Actemra 162mg for SC Injection

Cardiovascular Diseases

Sigmart

Indications:

  1. Angina

Sigmart Tablets 5mg Sigmart Tablets 5mg

Oncology

Alecensa

Indications:

  1. Alecensa is indicated for the treatment of patients with ALK-positive, advanced non-small cell lung cancer (NSCLC).

Alecensa capsules 150mg Alecensa capsules 150mg

Granocyte

Indications:

  1. Mobilization of hematopoietic stem cells into peripheral blood
  2. Acceleration of the increase in the neutrophil count in hematopoietic stem cells transplantation
  3. Cancer chemotherapy-induced neutropenia
  4. Neutropenia in myelodysplastic syndrome
  5. Congenital or idiopathic neutropenia

Granocyte 100 Granocyte 100

Granocyte 250 Granocyte 250

  • Print
  • 繁体中文视窗